1340 (1340) Fair Value & Analysis

Consumer Defensive · Market cap HK$81.9M

1 1340 1340 · HK

PriceHK$0.0730

Fair ValueHK$0.0854

Upside+17.0%

Quality63/100

Watch 1340 for free — get notified when fair value or trend changes. Watch for free

Evidence: Low Range HK$0.0562 – HK$0.1073

Fair value as of: Jul 2, 2026

From 3 valuation models · updated today

Share price +13.6% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.0331 – HK$0.1080 · fair‑value band HK$0.0562 – HK$0.1073 · the HK$0.0730 price screens below the HK$0.0854 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1340 (1340) currently trades at HK$0.0730, while our model-based Fair Value estimate is HK$0.0854 — implying the stock looks roughly 17.0% undervalued today. We read business quality at 63/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

Over the trailing twelve months, 1340 generated revenue of HK$210M at a net margin of -7.4%. It earns a return on equity of -4.0%. The balance sheet holds a net cash position of HK$24.6M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$210M

Revenue growth (YoY) +1,522%

Net margin -7.4%

Return on equity -4.0%

Free cash flow −HK$364M FY2025

Operating margin -5.0%

More key figures

EPS (TTM) HK$-0.0100

Net cash HK$24.6M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1340 reported revenue of HK$210M in FY2025 versus HK$81.3M in FY2021, a compound +26.7%/yr. Reported net income was −HK$15.6M in FY2025.

Revenue +26.7%/yr

FY21 HK$81.3M

FY22 HK$72.9M

FY23 HK$68.3M

FY24 HK$44.3M

FY25 HK$210M

Net income

FY21 −HK$31.8M

FY22 −HK$5.6M

FY23 −HK$144M

FY24 −HK$24.5M

FY25 −HK$15.6M

Is 1340 fairly valued? → Check now

Similar stocks

6 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Nestlé S.A NESN	CHF 79.73	CHF 55.79	-30%
Foshan Haitian Flavouring and Food Company 603288	¥34.03	¥23.66	-30%
Nestlé India Limited NESTLEIND	₹1,386	₹278.10	-80%
3288 3288	HK$30.26	HK$27.44	-9%
Grupo Bimbo, S.A. BIMBOA	57.10 MXN	45.03 MXN	-21%
Uni-President Enterprises Corp 1216	75.60 TWD	55.53 TWD	-27%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1340 (1340) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.0854 versus a price of HK$0.0730 — about +17% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 1340?

Our model-based fair value for 1340 is HK$0.0854 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.0730.

What is the quality score of 1340?

1340 has a Quality Score of 63/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1340 (1340)?

1340 reported trailing-twelve-month revenue of about HK$210M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1340?

The net profit margin of 1340 is about -7.4%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.